| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner
9 companies
Bain Capital Life Sciences Investors, LLC is a 10% Owner at HTFL, with reported holdings spanning 9 companies. Recent filings cover 12 purchases and 4 sales. Those positions are worth an estimated $483.7M at current prices.
Our model assigns Bain Capital Life Sciences Investors, LLC a below-average insider score of 48/100, based on 11 past trades. Over a 12-month horizon, 25.0% of those trades were profitable, with an average 12-month return of -26.0%.
Bain Capital Life Sciences Investors, LLC's largest disclosed position is in HTFL as 10% Owner, worth about $253.9M. The recent filings there lean toward selling, a net 2,000,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | HTFL Heartflow, Inc. | 10% Owner | Sell | 2,000,000 | $29.45 | $58,898,336.45 | -19.1% | -15.9% | - | |
| Feb 19, 2025 | SLDB Solid Biosciences Inc. | 10% Owner | Buy | 1,000,000 | $4.03 | $4,030,000.00 | +24.8% | -54.4% | -9.1% | |
| Jan 8, 2025 | OLMA Olema Pharmaceuticals, Inc. | 10% Owner | Buy | 300,000 | $5.76 | $1,727,370.00 | +4.0% | -46.8% | +344.7% | |
| Feb 12, 2024 | KYTX Kyverna Therapeutics, Inc. | 10% Owner | Buy | 450,000 | $22.00 | $9,900,000.00 | +16.6% | -51.1% | -90.2% | |
| May 25, 2023 | ANNX Annexon, Inc. | 10% Owner | Buy | 300,000 | $2.13 | $639,720.00 | +5.6% | +43.8% | +136.2% | |
| Dec 10, 2021 | XLO Xilio Therapeutics, Inc. | 10% Owner | Buy | 42,469 | $9.66 | $410,161.39 | +1.5% | -24.1% | -77.6% | |
| Jul 19, 2021 | RPID Rapid Micro Biosystems, Inc. | 10% Owner | Buy | 100,000 | $20.00 | $2,000,000.00 | +1.2% | -11.0% | -78.3% | |
| Jul 28, 2020 | ANNX Annexon, Inc. | 10% Owner | Buy | 400,000 | $17.00 | $6,800,000.00 | +14.1% | - | - | |
| Feb 4, 2020 | ARQT Arcutis Biotherapeutics, Inc. | 10% Owner | Buy | 294,117 | $17.00 | $4,999,989.00 | +8.0% | - | - | |
| Jul 24, 2018 | REPL Replimune Group, Inc. | 10% Owner | Buy | 500,000 | $15.00 | $7,500,000.00 | +21.4% | - | - |